β-arrestin 1 transfection induced cell death in high grade glioma in vitro

References

• DeWire, S. M.; Ahn, S.; Lefkowitz, R. J.; Shenoy, S. K. Beta-arrestins and Cell Signaling. Annu. Rev. Physiol. 2007, 69, 483. DOI: 10.1146/annurev.physiol.69.022405.154749.
   PubMed Web of Science ®Google Scholar
• Dalle, S.; Ricketts, W.; Imamura, T.; Vollenweider, P.; Olefsky, J. M. Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling Components. J. Biol. Chem. 2001, 276, 15688–15695. DOI: 10.1074/jbc.M010884200.
   PubMed Web of Science ®Google Scholar
• Lin, F. T.; Daaka, Y.; Lefkowitz, R. J. Beta-arrestins Regulate Mitogenic Signaling and Clathrin-mediated Endocytosis of the Insulin-like Growth Factor I Receptor. J. Biol. Chem. 1998, 273, 31640–31643. DOI: 10.1074/jbc.273.48.31640.
   PubMed Web of Science ®Google Scholar
• Kim, J.; Ahn, S.; Guo, R.; Daaka, Y. Regulation of Epidermal Growth Factor Receptor Internalization by G Protein-coupled Receptors. Biochemistry. 2003, 42, 2887–2894. DOI: 10.1021/bi026942t.
   PubMed Web of Science ®Google Scholar
• Hobson, J. P.; Rosenfeldt, H. M.; Barak, L. S.; Olivera, A.; Poulton, S.; Caron, M. G.; Milstien, S.; Spiegel, S. Role of the Sphingosine-1-phosphate Receptor Edg-1 in Pdgf-induced Cell Motility. Science. 2001, 291, 1800–1803. DOI: 10.1126/science.1057559.
   PubMed Web of Science ®Google Scholar
• Xu, C. B.; Zhang, Y.; Stenman, E.; Edvinsson, L. D-erythro-n,n-dimethylsphingosine Inhibits Bfgf-induced Proliferation of Cerebral, Aortic and Coronary Smooth Muscle Cells. Atherosclerosis. 2002, 164, 237–243. DOI: 10.1016/S0021-9150(02)00100-4.
   PubMed Web of Science ®Google Scholar
• DeFea, K.; Zalevsky, J.; Thoma, M.; Dery, O.; Mullins, R.; Bunnett, N. Β-arrestin–dependent Endocytosis of Proteinase-activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2. J. Cell Biol. 2000, 148, 1267–1282. DOI: 10.1083/jcb.148.6.1267.
   PubMed Web of Science ®Google Scholar
• DeFea, K.; Vaughn, Z.; O’bryan, E.; Nishijima, D.; Dery, O.; Bunnett, N. The Proliferative and Antiapoptotic Effects of Substance P are Facilitated by Formation of a β-arrestin-dependent Scaffolding Complex. Proc. National Academy Sci. 2000, 97, 11086–11091. DOI: 10.1073/pnas.190276697.
   PubMed Web of Science ®Google Scholar
• McDonald, P. H.; Chow, C.-W.; Miller, W. E.; Laporte, S. A.; Field, M. E.; Lin, F.-T.; Davis, R. J.; Lefkowitz, R. J. Β-arrestin 2: A Receptor-regulated Mapk Scaffold for the Activation of Jnk3. Science. 2000, 290, 1574–1577. DOI: 10.1126/science.290.5496.1574.
   PubMed Web of Science ®Google Scholar
• Miller, W. E.; McDonald, P. H.; Cai, S. F.; Field, M. E.; Davis, R. J.; Lefkowitz, R. J. Identification of a Motif in the Carboxyl Terminus of β-arrestin2 Responsible for Activation of Jnk3. J. Biol. Chem. 2001, 276, 27770–27777. DOI: 10.1074/jbc.M102264200.
   PubMed Web of Science ®Google Scholar
• Sun, Y.; Cheng, Z.; Ma, L.; Pei, G. Β-arrestin2 Is Critically Involved in Cxcr4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of P38 Mapk Activation. J. Biol. Chem. 2002, 277, 49212–49219. DOI: 10.1074/jbc.M207294200.
   PubMed Web of Science ®Google Scholar
• Ma, L.; Pei, G. Β-arrestin Signaling and Regulation of Transcription. J. Cell Sci. 2007, 120, 213–218. DOI: 10.1242/jcs.03338.
   PubMed Web of Science ®Google Scholar
• Tocci, P.; Cianfrocca, R.; Di Castro, V.; Rosanò, L.; Sacconi, A.; Donzelli, S.; Bonfiglio, S.; Bucci, G.; Vizza, E.; Ferrandina, G. Β-arrestin1/yap/mutant P53 Complexes Orchestrate the Endothelin a Receptor Signaling in High-grade Serous Ovarian Cancer. Nat. Commun. 2019, 10, 1–15. DOI: 10.1038/s41467-019-11045-8.
   PubMed Web of Science ®Google Scholar
• Lan, T.; Wang, H.; Zhang, Z.; Zhang, M.; Qu, Y.; Zhao, Z.; Fan, X.; Zhan, Q.; Song, Y.; Yu, C. Downregulation of β-arrestin 1 Suppresses Glioblastoma Cell Malignant Progression Vis Inhibition of Src Signaling. Exp. Cell Res. 2017, 357, 51–58. DOI: 10.1016/j.yexcr.2017.04.023.
   PubMed Web of Science ®Google Scholar
• Lattin, J.; Zidar, D. A.; Schroder, K.; Kellie, S.; Hume, D. A.; Sweet, M. J. G‐protein‐coupled Receptor Expression, Function, and Signaling in Macrophages. J. Leukocyte Biol. 2007, 82, 16–32. DOI: 10.1189/jlb.0107051.
   PubMed Web of Science ®Google Scholar
• Parruti, G.; Peracchia, F.; Sallese, M.; Ambrosini, G.; Masini, M.; Rotilio, D.; De Blasi, A. Molecular Analysis of Human Beta-arrestin-1: Cloning, Tissue Distribution, and Regulation of Expression. Identification of Two Isoforms Generated by Alternative Splicing. J. Biol. Chem. 1993, 268, 9753–9761.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Guan, E.; Roderiquez, G.; Calvert, V.; Alvarez, R.; Norcross, M. A. Role of Tyrosine Phosphorylation in Ligand-independent Sequestration of Cxcr4 in Human Primary Monocytes-macrophages. J. Biol. Chem. 2001, 276, 49236–49243. DOI: 10.1074/jbc.M108523200.
   PubMed Web of Science ®Google Scholar
• Aragay, A.; Mellado, M.; Frade, J.; Martin, A.; Jimenez-Sainz, M.; Martinez-A, C.; Mayor, F. Monocyte Chemoattractant Protein-1-induced Ccr2b Receptor Desensitization Mediated by the G Protein-coupled Receptor Kinase 2. Proc. National Academy Sci. 1998, 95, 2985–2990. DOI: 10.1073/pnas.95.6.2985.
   PubMed Web of Science ®Google Scholar
• Basher, F.; Fan, H.; Zingarelli, B.; Borg, K. T.; Luttrell, L. M.; Tempel, G. E.; Halushka, P. V.; Cook, J. A. Β-arrestin 2: A Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes. Int. J. Clin. Exp. Med. 2008, 1, 32.
   PubMed Web of Science ®Google Scholar
• Barlic, J.; Andrews, J. D.; Kelvin, A. A.; Bosinger, S. E.; DeVries, M. E.; Xu, L.; Dobransky, T.; Feldman, R. D.; Ferguson, S. S.; Kelvin, D. J. Regulation of Tyrosine Kinase Activation and Granule Release through β-arrestin by Cxcr1. Nat. Immunol. 2000, 1, 227–233. DOI: 10.1038/79767.
   PubMed Web of Science ®Google Scholar
• Yu, M.-C.; Su, -L.-L.; Zou, L.; Liu, Y.; Wu, N.; Kong, L.; Zhuang, Z.-H.; Sun, L.; Liu, H.-P.; Hu, J.-H. An Essential Function for β-arrestin 2 in the Inhibitory Signaling of Natural Killer Cells. Nat. Immunol. 2008, 9, 898. DOI: 10.1038/ni.1635.
   PubMed Web of Science ®Google Scholar
• Bari, R.; Bell, T.; Leung, W.-H.; Vong, Q. P.; Chan, W. K.; Das Gupta, N.; Holladay, M.; Rooney, B.; Leung, W. Significant Functional Heterogeneity among Kir2dl1 Alleles and a Pivotal Role of Arginine245. Blood. 2009, 114, 5182–5190. DOI: 10.1182/blood-2009-07-231977.
   PubMed Web of Science ®Google Scholar
• Jacob, C.; Yang, P.-C.; Darmoul, D.; Amadesi, S.; Saito, T.; Cottrell, G. S.; Coelho, A.-M.; Singh, P.; Grady, E. F.; Perdue, M. Mast Cell Tryptase Controls Paracellular Permeability of the Intestine Role of Protease-activated Receptor 2 and β-arrestins. J. Biol. Chem. 2005, 280, 31936–31948. DOI: 10.1074/jbc.M506338200.
   PubMed Web of Science ®Google Scholar
• Vibhuti, A.; Gupta, K.; Subramanian, H.; Guo, Q.; Ali, H. Distinct and Shared Roles of β-arrestin-1 and β-arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells. PloS One. 2011, 6, e19585. DOI: 10.1371/journal.pone.0019585.
   PubMed Web of Science ®Google Scholar
• Fong, A. M.; Premont, R. T.; Richardson, R. M.; Yen-Rei, A. Y.; Lefkowitz, R. J.; Patel, D. D. Defective Lymphocyte Chemotaxis in β-arrestin2-and Grk6-deficient Mice. Proc. National Academy Sci. 2002, 99, 7478–7483.
   PubMed Web of Science ®Google Scholar
• Bjørgo, E.; Solheim, S. A.; Abrahamsen, H.; Baillie, G. S.; Brown, K. M.; Berge, T.; Okkenhaug, K.; Houslay, M. D.; Taskén, K. Cross Talk between Phosphatidylinositol 3-kinase and Cyclic Amp (Camp)-protein Kinase a Signaling Pathways at the Level of a Protein Kinase b/β-arrestin/camp Phosphodiesterase 4 Complex. Mol. Cell. Biol. 2010, 30, 1660–1672. DOI: 10.1128/MCB.00696-09.
   PubMed Web of Science ®Google Scholar
• Bjorgo, E.; Tasken, K. Role of Camp Phosphodiesterase 4 in Regulation of T-cell Function. Critical Rev.™ In Immunol. 2006, 26: 443-452.
   Google Scholar
• Baillie, G. S.; Houslay, M. D. Arrestin Times for Compartmentalised Camp Signalling and Phosphodiesterase-4 Enzymes. Curr. Opin. Cell Biol. 2005, 17, 129–134. DOI: 10.1016/j.ceb.2005.01.003.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. X.; Li, X. F.; Yuan, G. Q.; Hu, H.; Song, X. Y.; Li, J. Y.; Miao, X. K.; Zhou, T. X.; Yang, W. L.; Zhang, X. W.; et al. Beta-arrestin 1 Has an Essential Role in Neurokinin-1 Receptor-mediated Glioblastoma Cell Proliferation and G2/m Phase Transition. J. Biol. Chem. 2017, 292, 8933–8947. DOI: 10.1074/jbc.M116.770420.
   PubMed Web of Science ®Google Scholar
• Lan, T.; Wang, H.; Zhang, Z.; Zhang, M.; Qu, Y.; Zhao, Z.; Fan, X.; Zhan, Q.; Song, Y.; Yu, C. Downregulation of Beta-arrestin 1 Suppresses Glioblastoma Cell Malignant Progression Vis Inhibition of Src Signaling. Exp. Cell Res. 2017, 357, 51–58.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Stevens, M. F.; Bradshaw, T. D. Temozolomide: Mechanisms of Action, Repair and Resistance. Curr. Mol. Pharmacol. 2012, 5, 102–114. DOI: 10.2174/1874467211205010102.
   PubMedGoogle Scholar
• Zhang, J.; Stevens, M. F.; Hummersone, M.; Madhusudan, S.; Laughton, C. A.; Bradshaw, T. D. Certain Imidazotetrazines Escape o6-methylguanine-DNA Methyltransferase and Mismatch Repair. Oncology. 2011, 80, 195–207. DOI: 10.1159/000327837.
   PubMed Web of Science ®Google Scholar
• Danciulescu, O. T.; Folcuti, R.; Dricu, A. Temozolomide and Targeted Therapy against Epidermal Growth Factor Receptor in Glioma. Int. J. Clin. Exp. Med. 2016, 9: 15249-15261
   Web of Science ®Google Scholar
• Lefkowitz, R. J.;. The Superfamily of Heptahelical Receptors. Nat. Cell Biol. 2000, 2, E133–136. DOI: 10.1038/35017152.
   PubMed Web of Science ®Google Scholar
• Lefkowitz, R. J.; Shenoy, S. K. Transduction of Receptor Signals by Beta-arrestins. Science. 2005, 308, 512–517. DOI: 10.1126/science.1109237.
   PubMed Web of Science ®Google Scholar
• Kobilka, B. K.;. G Protein Coupled Receptor Structure and Activation. Biochim. Biophys. Acta. 2007, 1768, 794–807. DOI: 10.1016/j.bbamem.2006.10.021.
   PubMed Web of Science ®Google Scholar
• Whalen, E. J.; Rajagopal, S.; Lefkowitz, R. J. Therapeutic Potential of Beta-arrestin- and G Protein-biased Agonists. Trends Mol. Med. 2011, 17, 126–139. DOI: 10.1016/j.molmed.2010.11.004.
   PubMed Web of Science ®Google Scholar
• Su, Y.; Raghuwanshi, S. K.; Yu, Y.; Nanney, L. B.; Richardson, R. M.; Richmond, A. Altered Cxcr2 Signaling in Beta-arrestin-2-deficient Mouse Models. J. Immunol. 2005, 175, 5396–5402. DOI: 10.4049/jimmunol.175.8.5396.
   PubMed Web of Science ®Google Scholar
• Huttenrauch, F.; Pollok-Kopp, B.; Oppermann, M. G Protein-coupled Receptor Kinases Promote Phosphorylation and Beta-arrestin-mediated Internalization of Ccr5 Homo- and Hetero-oligomers. J. Biol. Chem. 2005, 280, 37503–37515. DOI: 10.1074/jbc.M500535200.
   PubMed Web of Science ®Google Scholar
• Gilliland, C. T.; Salanga, C. L.; Kawamura, T.; Trejo, J.; Handel, T. M. The Chemokine Receptor Ccr1 Is Constitutively Active, Which Leads to G Protein-independent, Beta-arrestin-mediated Internalization. J. Biol. Chem. 2013, 288, 32194–32210. DOI: 10.1074/jbc.M113.503797.
   PubMed Web of Science ®Google Scholar
• Buchanan, F. G.; Gorden, D. L.; Matta, P.; Shi, Q.; Matrisian, L. M.; DuBois, R. N. Role of Beta-arrestin 1 in the Metastatic Progression of Colorectal Cancer. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 1492–1497. DOI: 10.1073/pnas.0510562103.
   PubMed Web of Science ®Google Scholar
• Lundgren, K.; Tobin, N. P.; Lehn, S.; Stal, O.; Ryden, L.; Jirstrom, K.; Landberg, G. Stromal Expression of Beta-arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer. J. Mol. Diagn. 2011, 13, 340–351. DOI: 10.1016/j.jmoldx.2011.01.009.
   PubMed Web of Science ®Google Scholar
• Rosano, L.; Cianfrocca, R.; Tocci, P.; Spinella, F.; Di Castro, V.; Caprara, V.; Semprucci, E.; Ferrandina, G.; Natali, P. G.; Bagnato, A. Endothelin a Receptor/beta-arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy. Cancer Res. 2014, 74, 7453–7464. DOI: 10.1158/0008-5472.CAN-13-3133.
   PubMed Web of Science ®Google Scholar
• Mandell, J. W.; Glass, G.; Gianchandani, E. P.; Locke, C. N.; Amos, S.; Bourne, T. D.; Schiff, D.; Papin, J. A. Dephosphorylation of Beta-arrestin 1 in Glioblastomas. J. Neuropathol. Exp. Neurol. 2009, 68, 535–541. DOI: 10.1097/NEN.0b013e3181a2b8F4-9.
   PubMed Web of Science ®Google Scholar
• Mogosanu, G. D.; Buteică, S. A.; Purcaru, S. O.; Croitoru, O.; Georgescu, A. M.; Serban, F.; Tătăranu, L. G.; Alexandru, O.; Dricu, A. Rationale and in Vitro Efficacy of Ligustrum Vulgare Hydroalcoholic Extract for the Treatment of Brain Tumors. Int. J. Clin. Exp. Pathol. 2016, 9, 8286–8296.
   Web of Science ®Google Scholar
• Artene, S.; Folcuti, C.; DRICU, A. Β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells. Current Health Sci. J. 2017, 43, 112.
   PubMedGoogle Scholar
• Carapancea, M.; Cosaceanu, D.; Budiu, R.; Kwiecinska, A.; Tataranu, L.; Ciubotaru, V.; Alexandru, O.; Banita, M.; Pisoschi, C.; Backlund, M. L.; et al. Dual Targeting of Igf-1r and Pdgfr Inhibits Proliferation in High-grade Gliomas Cells and Induces Radiosensitivity in Jnk-1 Expressing Cells. J. Neuro-oncol. 2007, 85, 245–254. DOI: 10.1007/s11060-007-9417-0.
   PubMed Web of Science ®Google Scholar